tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LCTX Stock Latest News

De-Risked Cell Therapy Platform and Roche Partnership Momentum Underpin Buy Rating on Lineage (LCTX)
RatingsDe-Risked Cell Therapy Platform and Roche Partnership Momentum Underpin Buy Rating on Lineage (LCTX)
9d ago
LCTX
Lineage Cell Therapeutics receives iPSC line from Factor Bioscience
PremiumThe Fly
Lineage Cell Therapeutics receives iPSC line from Factor Bioscience
9d ago
LCTX
Lineage Therap Withdraws CIRM Grant Application
PremiumCompany Announcements
Lineage Therap Withdraws CIRM Grant Application
2M ago
8K
LCTX
Lineage Cell says first OpRegen development milestone under Roche pact achieved
PremiumThe Fly
Lineage Cell says first OpRegen development milestone under Roche pact achieved
2M ago
CHRO
LCTX
Buy Rating Affirmed for Lineage Cell Therapeutics Amid Significant Progress in OpRegen Program and Strategic Partnership with Roche
PremiumRatings
Buy Rating Affirmed for Lineage Cell Therapeutics Amid Significant Progress in OpRegen Program and Strategic Partnership with Roche
2M ago
LCTX
Lineage Cell’s OpRegen shows evidence of progress, says H.C. Wainwright
PremiumThe FlyLineage Cell’s OpRegen shows evidence of progress, says H.C. Wainwright
2M ago
CHRO
LCTX
Lineage Therap Secures $5M Milestone Payment
Premium
Company Announcements
Lineage Therap Secures $5M Milestone Payment
2M ago
8K
LCTX
Lineage Therap Sells 12 Million Shares to Janus
Premium
Company Announcements
Lineage Therap Sells 12 Million Shares to Janus
2M ago
8K
LCTX
Positive Buy Rating for Lineage Cell Therapeutics Driven by Clinical Progress and Financial Stability
PremiumRatings
Positive Buy Rating for Lineage Cell Therapeutics Driven by Clinical Progress and Financial Stability
2M ago
LCTX
Lineage Cell Therapeutics: Progress Amid Financial Challenges
PremiumCompany Announcements
Lineage Cell Therapeutics: Progress Amid Financial Challenges
2M ago
LCTX
Lineage Cell Therapeutics Reports Q3 2025 Results
PremiumCompany Announcements
Lineage Cell Therapeutics Reports Q3 2025 Results
2M ago
LCTX
Lineage Cell Therapeutics reports Q3 EPS (13c), consensus (3c)
PremiumThe Fly
Lineage Cell Therapeutics reports Q3 EPS (13c), consensus (3c)
2M ago
LCTX
Is LCTX a Buy, Before Earnings?
PremiumPre-EarningsIs LCTX a Buy, Before Earnings?
2M ago
LCTX
Lineage Cell Therapeutics Advances in Spinal Cord Injury Treatment with DOSED Study
Premium
Company Announcements
Lineage Cell Therapeutics Advances in Spinal Cord Injury Treatment with DOSED Study
3M ago
LCTX
Lineage Cell Therapeutics: Buy Rating Affirmed on Innovative Cell Therapy Advancements and Strategic Collaborations
Premium
Ratings
Lineage Cell Therapeutics: Buy Rating Affirmed on Innovative Cell Therapy Advancements and Strategic Collaborations
4M ago
LCTX
Lineage Cell Therapeutics initiates new islet cell transplant program
PremiumThe Fly
Lineage Cell Therapeutics initiates new islet cell transplant program
4M ago
LCTX
Lineage Cell Therapeutics’ Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Lineage Cell Therapeutics’ Earnings Call: Progress Amid Challenges
5M ago
LCTX
Buy Recommendation for Lineage Cell Therapeutics Driven by Strategic Partnerships and Financial Positioning
PremiumRatings
Buy Recommendation for Lineage Cell Therapeutics Driven by Strategic Partnerships and Financial Positioning
5M ago
LCTX
Strategic Partnerships and Promising Trial Results Bolster Buy Rating for Lineage Cell Therapeutics
PremiumRatings
Strategic Partnerships and Promising Trial Results Bolster Buy Rating for Lineage Cell Therapeutics
5M ago
LCTX
Lineage Therap Partners with WDI for Hearing Loss Research
PremiumCompany AnnouncementsLineage Therap Partners with WDI for Hearing Loss Research
5M ago
8K
LCTX
Lineage Cell Therapeutics enters research pact with William Demant Invest
Premium
The Fly
Lineage Cell Therapeutics enters research pact with William Demant Invest
5M ago
LCTX
Promising Developments and Strong Financial Position Support Buy Rating for Lineage Cell Therapeutics
Premium
Ratings
Promising Developments and Strong Financial Position Support Buy Rating for Lineage Cell Therapeutics
5M ago
LCTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >